Search for: All records

Coordination of the leucoverdazyl ligand 2,4-diisopropyl-6-(pyridin-2-yl)-1,4-dihydro-1,2,4,5-tetrazin-3(2H)-one VdH to Ru significantly weakens the ligand’s N-H bond. Electrochemical measurements show that the metalated leucoverdazyl Ru(VdH)(acetylacetonate)2 RuVdH has a lower pKa (-5 units), BDFE (-7 kcal/mol), and hydricity (-22 kcal/mol) than the free ligand. DFT calculations suggest that the increased acidity is in part attributable to the stabilization of the conjugate base Vd-. When free, Vd- distorts to avoid an 8πe- antiaromatic state, but it remains planar when bound to Ru. Proton-coupled electron transfer (PCET) behavior is observed for both the free and metalated leucoverdazyls. PCET equilibrium between Vd radical and TEMPOH affords a VdH BDFE that is in good agreement with that obtained from electrochemical methods. RuVd exhibits electrocatalytic PCET donor behavior. Under acidic conditions, it reduces the persistent trityl radical ·CAr3 (Ar = p-tert-butylphenyl) to the corresponding triarylmethane HCAr3 via net 1e-/1H+ transfer from RuVdH. 

The synthesis, structure, and reactivity of a series of cyclopentadienone and hydroxycyclopentadienyl 4,4’-dimethylbipyridine (dmbpy) iridium complexes (C5Tol2Ph2O)(dmbpy)IrCl 1, [(C5Tol2Ph2OH)(dmbpy)IrCl][OTf] 2 (C5Tol2Ph2O)(dmbpy)IrH 3, and [(C5Tol2Ph2OH)(dmbpy)IrH][OTf] 4 are described. The Ir(I) complexes 1 and 3 are active catalyst precursors for transfer hydrogenation of aldehydes, ketones, and N-heterocycles with HCO2H/Et3N under mild conditions. Model studies implicate the cationic iridium hydride, [(C5Tol2Ph2OH)(dmbpy)IrH][OTf] 4 as a key intermediate, as 4 reacts readily with acetone to generate isopropanol. Selectivity over hydrogenation of alkenes is enhanced compared to other Shvo-type catalysts, and only modest C=C hydrogenation observed when adjacent to polarizing functional groups. Catalytic hydrogenation likely proceeds by a metal-ligand bifunctional mechanism similar to related cyclopentadienone complexes 

Targeted delivery of nucleic acid therapeutics to the lungs could transform treatment options for pulmonary disease. We have previously developed oligomeric charge-altering releasable transporters (CARTs) for in vivo mRNA transfection and demonstrated their efficacy for use in mRNA-based cancer vaccination and local immunomodulatory therapies against murine tumors. While our previously reported glycine-based CART-mRNA complexes (G-CARTs/mRNA) show selective protein expression in the spleen (mouse, >99%), here, we report a new lysine-derived CART-mRNA complex (K-CART/mRNA) that, without additives or targeting ligands, shows selective protein expression in the lungs (mouse, >90%) following systemic IV administration. We further show that by delivering siRNA using the K-CART, we can significantly decrease expression of a lung-localized reporter protein. Blood chemistry and organ pathology studies demonstrate that K-CARTs are safe and well-tolerated. We report on the new step economical, organocatalytic synthesis (two steps) of functionalized polyesters and oligo-carbonate-co-α- aminoester K-CARTs from simple amino acid and lipid-based monomers. The ability to direct protein expression selectively in the spleen or lungs by simple, modular changes to the CART structure opens fundamentally new opportunities in research and gene therapy. 

The synthesis and degradation mechanisms of a class of pH-sensitive, rapidly degrading cationic poly(α-aminoester)s are described. These reactive, cationic polymers are stable at low pH in water, but undergo a fast and selective degradation at higher pH to liberate neutral diketopiperazines. Related materials incorporating oligo(α-amino ester)s have been shown to be effective gene delivery agents, as the charge-altering degradative behavior facilitates the delivery and release of mRNA and other nucleic acids in vitro and in vivo . Herein, we report detailed studies of the structural and environmental factors that lead to these rapid and selective degradation processes in aqueous buffers. At neutral pH, poly(α-aminoester)s derived from N -hydroxyethylglycine degrade selectively by a mechanism involving sequential 1,5- and 1,6-O→N acyl shifts to generate bis( N -hydroxyethyl) diketopiperazine. A family of structurally related cationic poly(aminoester)s was generated to study the structural influences on the degradation mechanism, product distribution, and pH dependence of the rate of degradation. The kinetics and mechanism of the pH-induced degradations were investigated by 1 H NMR, model reactions, and kinetic simulations. These results indicate that polyesters bearing α-ammonium groups and appropriately positioned N -hydroxyethyl substituents are readily cleaved (by intramolecular attack) or hydrolyzed, representing dynamic “dual function” materials that are initially polycationic and transform with changing environment to neutral products. 

We report the development of post-transcriptional chemical methods that enable control over CRISPR–Cas9 gene editing activity both in in vitro assays and in living cells. We show that an azide-substituted acyl imidazole reagent (NAI-N 3 ) efficiently acylates CRISPR single guide RNAs (sgRNAs) in 20 minutes in buffer. Poly-acylated (“cloaked”) sgRNA was completely inactive in DNA cleavage with Cas9 in vitro , and activity was quantitatively restored after phosphine treatment. Delivery of cloaked sgRNA and Cas9 mRNA into HeLa cells was enabled by the use of charge-altering releasable transporters (CARTs), which outperformed commercial transfection reagents in transfecting sgRNA co-complexed with Cas9 encoding functional mRNA. Genomic DNA cleavage in the cells by CRISPR–Cas9 was efficiently restored after treatment with phosphine to remove the blocking acyl groups. Our results highlight the utility of reversible RNA acylation as a novel method for temporal control of genome-editing function.